CLINICAL CANCER RESEARCH 期刊简介
Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, and molecular alterations or biomarkers that predict response or resistance to treatment. The Journal also prioritizes laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease.
Specific areas of interest include clinical and translational research in targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; novel applications of bioinformatics and biostatistics; immunotherapy and clinical immunology; gene therapy; radiobiology and radiation oncology; large-scale molecular characterization of human tumors; diagnostic biomarkers; innovative imaging and other novel methods with potential applicability to clinical investigation; clinical genetics; and detection of minimal disease.
临床癌症研究发表了创新的临床和转化癌症研究研究,弥合了实验室和诊所。该杂志对评估新疗法的临床试验特别感兴趣,并伴随着药理学研究以及预测对治疗反应或耐药性的分子改变或生物标志物。该杂志还优先研究新药和分子靶向药物的实验室和动物研究,这些药物和分子靶向药物有可能导致临床试验,并研究肿瘤发生的靶向机制,恶性表型的进展,和转移性疾病。
感兴趣的特定领域包括靶向治疗的临床和转化研究; 药物敏感性和耐药性机制; 药物遗传学和药物基因组学; 个性化医学; 生物信息学和生物统计学的新应用; 免疫治疗和临床免疫学; 基因治疗; 放射生物学和放射肿瘤学; 人类肿瘤的大规模分子表征; 诊断生物标志物; 具有潜在临床研究适用性的创新成像和其他新颖方法; 临床遗传学; 和微小疾病的检测。
期刊ISSN
|
1078-0432 |
影响指数
|
12.406 |
最新CiteScore值
|
18.20 查看CiteScore评价数据 |
最新自引率
|
2.20% |
官方指定润色网址
|
https://www.deeredit.com/?type=ss1 |
投稿语言要求
|
Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted. 建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率 |
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
杂志社征稿网址
hot |
https://www.peipusci.com/?type=10 |
通讯地址
|
AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404 |
偏重的研究方向(学科)
|
医学-肿瘤学 |
出版周期
|
Semimonthly |
出版年份
|
1995 |
出版国家/地区
|
UNITED STATES |
是否OA
|
No |
SCI期刊coverage
|
Science Citation Index Expanded(科学引文索引扩展) |
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
ONCOLOGY(肿瘤学)1区
否
|
|||||
最新的影响因子
|
12.406 | |||||
最新公布的期刊年发文量 |
|
|||||
总被引频次 | 292 | |||||
影响因子趋势图 |
近年的影响因子趋势图(整体平稳趋势)
|
2022年预警名单预测最新
最新CiteScore值
|
18.20
|
||||||||||||||
年文章数 | 621 | ||||||||||||||
SJR
|
5.427 | ||||||||||||||
SNIP
|
2.243 | ||||||||||||||
CiteScore排名
|
|
||||||||||||||
CiteScore趋势图 |
CiteScore趋势图
|
本刊同领域相关期刊
|
|
期刊名称 | IF值 |
INTEGRATIVE CANCER THERAPIES | 3.246 |
Hormones & Cancer | 3.83 |
ENDOCRINE-RELATED CANCER | 5.621 |
Frontiers of Medicine | 4.546 |
Molecular Medicine Reports | 2.922 |
Molecular Therapy-Oncolytics | 7.128 |
American Journal of Translational Research | 4.019 |
BREAST | 4.336 |
Breast Care | 2.831 |
本刊同分区等级的相关期刊
|
|
期刊名称 | IF值 |
ONCOGENE | 9.768 |
Molecular Cancer | 27.127 |
CANCER LETTERS | 8.592 |
CANCER RESEARCH | 12.574 |
LANCET ONCOLOGY | 40.903 |
Cancer Discovery | 39.003 |
ANNALS OF ONCOLOGY | 32.646 |
NATURE REVIEWS CANCER | 60.109 |
CANCER TREATMENT REVIEWS | 11.99 |
分享者 | 点评内容 |